Not all members of the pregnancy-specific glycoprotein family are created equal

妊娠特异性糖蛋白家族的所有成员并非生而平等

基本信息

项目摘要

PROJECT SUMMARY The importance of factors secreted by the placenta as mediators of the immunological adjustments needed to accommodate the genetically different mother and fetus in species with hemochorial placentation (rodents, non- human primates and humans) is well recognized. Conflicting interests for resources between mother and offspring are hypothesized to drive an evolutionary arms race during mammalian pregnancy. This can result in gene duplication events giving raise to protein families, such as the pregnancy-specific glycoprotein (PSG) family, which are not uncommon in the placenta. Monocyte (M0) and macrophage (Mϕ) dysregulation are implicated in pregnancy pathologies such as preeclampsia (PE) and preterm birth and these cells of the innate immune system are primarily responsible for the release of TNF, a potent pro-inflammatory cytokine. While the TNF response contributes to trophoblast invasion in the early decidua and to parturition, increased levels of TNF are also associated with adverse pregnancy outcomes. Therefore, the temporal and spatial regulation of inflammation represents a complex and essential process required for pregnancy success. Human PSGs, a family of ten proteins secreted by placental trophoblasts to the maternal circulation throughout pregnancy, are composed of 3 or 4 Ig-like domains. While PSGs have expanded from a single gene by duplication, it remains unknown whether after expansion, these genes have acquired different functions. Moreover, due to sequence similarities, specific antibodies that differentiate each member of the human PSG family are not available, but studies at the mRNA level have indicated that they are expressed at different levels and times during gestation. PSG1 has anti-inflammatory activities in vitro and in vivo and the concentration of PSG1 was found to be lower than normal in African American women diagnosed with PE. In contrast, PSG9 was reported to be upregulated in PE. Recently, we also observed that treatment of M0 and Mϕ with PSG9 but not with PSG1, PSG4 and PSG7 resulted in increased TNFsecretion. Based on these observations, we propose an innovative hypothesis that PSG9 has a unique function among human PSGs via binding to a specific cellular receptor in M0 and Mϕ resulting in the production of pro-inflammatory cytokines by these cells. We propose to test our hypothesis with the following Specific Aims: (1) Determine whether PSG9 is unique among all the human PSGs in its ability to induce pro-inflammatory cytokines in monocyte/macrophages and define the domain in PSG9 involved in this activity. (2) Identify the cellular receptor of PSG9 in monocytes/macrophages associated with its ability to induce TNF in these cells. Validation of the pro-inflammatory activity of PSG9 and identification of its receptor and its potential targeting will enable the development of diagnostic tools and novel therapeutic interventions to address the etiology of some pathological pregnancies. The long-term benefit to surviving offspring and the mother could have enormous economic and social consequences.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gabriela S Dveksler其他文献

Gabriela S Dveksler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gabriela S Dveksler', 18)}}的其他基金

Not all members of the pregnancy-specific glycoprotein family are created equal
妊娠特异性糖蛋白家族的所有成员并非生而平等
  • 批准号:
    10615689
  • 财政年份:
    2022
  • 资助金额:
    $ 18.99万
  • 项目类别:
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
  • 批准号:
    10434937
  • 财政年份:
    2021
  • 资助金额:
    $ 18.99万
  • 项目类别:
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
  • 批准号:
    10302501
  • 财政年份:
    2021
  • 资助金额:
    $ 18.99万
  • 项目类别:
Therapeutic potential of PSG1 administration in GVHD
PSG1 给药在 GVHD 中的治疗潜力
  • 批准号:
    9111289
  • 财政年份:
    2016
  • 资助金额:
    $ 18.99万
  • 项目类别:
Pregnancy specific glycoprotein 1 activates transforming growth factor beta
妊娠特异性糖蛋白 1 激活转化生长因子 β
  • 批准号:
    8533727
  • 财政年份:
    2012
  • 资助金额:
    $ 18.99万
  • 项目类别:
Pregnancy specific glycoprotein 1 activates transforming growth factor beta
妊娠特异性糖蛋白 1 激活转化生长因子 β
  • 批准号:
    8359204
  • 财政年份:
    2012
  • 资助金额:
    $ 18.99万
  • 项目类别:
Immunomodulation by Pregnancy Specific Glycoprotein 17
妊娠特异性糖蛋白 17 的免疫调节
  • 批准号:
    6688455
  • 财政年份:
    2002
  • 资助金额:
    $ 18.99万
  • 项目类别:
Immunomodulation by Pregnancy Specific Glycoprotein 17
妊娠特异性糖蛋白 17 的免疫调节
  • 批准号:
    6823250
  • 财政年份:
    2002
  • 资助金额:
    $ 18.99万
  • 项目类别:
Immunomodulation by Pregnancy Specific Glycoprotein 17
妊娠特异性糖蛋白 17 的免疫调节
  • 批准号:
    6580154
  • 财政年份:
    2002
  • 资助金额:
    $ 18.99万
  • 项目类别:
Immunomodulation by Pregnancy Specific Glycoprotein 17
妊娠特异性糖蛋白 17 的免疫调节
  • 批准号:
    6982814
  • 财政年份:
    2002
  • 资助金额:
    $ 18.99万
  • 项目类别:

相似海外基金

Broadening Participation Research: Understanding faculty attitudes, competency, and perceptions of providing career advising to African American STEM students at HBCUs
扩大参与研究:了解教师对 HBCU 的非裔美国 STEM 学生提供职业建议的态度、能力和看法
  • 批准号:
    2306671
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
    Continuing Grant
Cognitive Behavioral Faith-based Depression Intervention For African American Adults (CB-FAITH): An Effectiveness And Implementation Trial
非裔美国成年人基于认知行为信仰的抑郁干预 (CB-FAITH):有效性和实施试验
  • 批准号:
    10714464
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
  • 批准号:
    10723833
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
  • 批准号:
    10811498
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness-based Stress Reduction for Justice-Involved Black/African American Female Adolescents and Parents/Caregivers
探索创伤后应激障碍 (PTSD) 症状、障碍和促进因素,为涉及正义的黑人/非裔美国女性青少年和父母/照顾者进行基于正念的减压
  • 批准号:
    10593806
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
BCSER - PVEST: A Dynamic Framework for Investigating STEM Interest, Attitude and Identity Among African American Middle School Students
BCSER - PVEST:调查非裔美国中学生 STEM 兴趣、态度和身份的动态框架
  • 批准号:
    2327055
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
    Standard Grant
Making the Connection: Understanding the dynamic social connections impacting type 2 diabetes management among Black/African American men
建立联系:了解影响黑人/非裔美国男性 2 型糖尿病管理的动态社会联系
  • 批准号:
    10782674
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
Building a Community-Based Mental Health Literacy Intervention for African American Young Adults
为非裔美国年轻人建立基于社区的心理健康素养干预措施
  • 批准号:
    10738855
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
African American Literature in "post" Post-Racial America
“后”后种族美国中的非裔美国文学
  • 批准号:
    23K00376
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA methylation in Older African American Women at Risk for Cardiometabolic Disease
基于种族的减压干预措施对有心血管代谢疾病风险的老年非洲裔美国女性的健康、炎症和 DNA 甲基化的影响
  • 批准号:
    10633624
  • 财政年份:
    2023
  • 资助金额:
    $ 18.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了